FID 123320
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FID 123320, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations [Phase 3]